2022 annual financial data
X4 Pharmaceuticals 2022 Operating margin
X4 Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -87,569,000 USD and net income was -93,867,000 USD.
Operating cash flow was -77,102,000 USD.
Get free X4 Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -87,569,000 USD
- Net income
- -93,867,000 USD
- Operating cash flow
- -77,102,000 USD